《Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity》 was published in ACS Infectious Diseases in 2020. These research results belong to Villemagne, Baptiste; Machelart, Arnaud; Tran, Ngoc Chau; Flipo, Marion; Moune, Martin; Leroux, Florence; Piveteau, Catherine; Wohlkonig, Alexandre; Wintjens, Rene; Li, Xue; Gref, Ruxandra; Brodin, Priscille; Deprez, Benoit; Baulard, Alain R.; Willand, Nicolas. Application of 16982-21-1 The article mentions the following:
Killing more than one million people each year, tuberculosis remains the leading cause of death from a single infectious agent. The growing threat of multidrug-resistant strains of Mycobacterium tuberculosis stresses the need for alternative therapies. EthR, a mycobacterial transcriptional regulator, is involved in the control of the bioactivation of the second-line drug ethionamide. We have previously reported the discovery of in vitro nanomolar boosters of ethionamide through fragment-based approaches. In this study, we have further explored the structure-activity and structure-property relationships in this chem. family. By combining structure-based drug design and in vitro evaluation of the compounds, we identified a new oxadiazole compound as the first fragment-based ethionamide booster which proved to be active in vivo, in an acute model of tuberculosis infection. In the part of experimental materials, we found many familiar compounds, such as Ethyl 2-amino-2-thioxoacetate(cas: 16982-21-1Application of 16982-21-1)
Ethyl 2-amino-2-thioxoacetate(cas: 16982-21-1) belongs to anime. Left-handed and right-handed forms (mirror-image configurations, known as optical isomers or enantiomers) are possible when all the substituents on the central nitrogen atom are different (i.e., the nitrogen is chiral). With amines, there is extremely rapid inversion in which the two configurations are interconverted.Application of 16982-21-1
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics